Other Stories

S. Korea approves ongoing remdesivir imports to treat COVID-19 Updated: 2020-07-26 13:41:34 KST

South Korea approved remdesivir for general, ongoing import.
The drug safety ministry announced there's a need for continuous supplies of the antiviral product, made by U.S.-based Gilead Sciences.
Preliminary reports have shown remdesivir can shorten the recovery time for severe cases of COVID-19 by 30 percent.
The ministry also approved six additional brands of test kits that can confirm infections within an hour.
These will be used for emergency cases when patients might need immediate surgery.
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.